Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment.
Ramaswamy A, Nayak L, Roy Moulik N, Sengar M, Chinnaswamy G, Jobanputra K, Shah MJ, Kapoor A, Joshi A, Kumar A, Gokarn A, Bonda A, Cheriyalinkal Parambil B, Prasad M, Bagal B, Dhamne C, Narula G, Jain H, Ghosh J, Thorat J, Bajpai J, Menon N, Khattry N, Bhargava P, Punatar S, Gulia S, Banavali S, Gupta S, Srinivas S, Rath S, Vora T, Noronha V, Patil VM, Ostwal V, Prabhash K. Ramaswamy A, et al. Among authors: nayak l. Cancer Med. 2020 Dec;9(23):8747-8753. doi: 10.1002/cam4.3423. Epub 2020 Oct 31. Cancer Med. 2020. PMID: 33128509 Free PMC article.
Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes.
Punatar S, Kalantri SA, Chichra A, Agrawal AK, Nayak L, Bonda A, Gokarn A, Bagal B, Mathew L, Kannan S, Khattry N. Punatar S, et al. Among authors: nayak l. Bone Marrow Transplant. 2021 Jul;56(7):1558-1562. doi: 10.1038/s41409-021-01213-0. Epub 2021 Jan 29. Bone Marrow Transplant. 2021. PMID: 33514924
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol.
Rajendra A, Jain H, Bonda VNA, Nayak L, Tembhare P, Shetty D, Thorat J, Jain H, Subramanian PG, Patkar N, Chatterjee G, Khattry N, Gokarn A, Punatar S, Mokal S, Bagal B, Sengar M. Rajendra A, et al. Among authors: nayak l. Blood Adv. 2021 Mar 9;5(5):1178-1193. doi: 10.1182/bloodadvances.2020003526. Blood Adv. 2021. PMID: 33635331 Free PMC article.
Lenalidomide as a Potent Inducer of Graft Versus Leukemia Effect in Patients with Hematologic Malignancies at High Risk of Relapse Post Allogeneic Stem Cell Transplant.
Vinodhini M, Punatar S, Gokarn A, Nayak L, Bonda A, Mathew L, Khattry N. Vinodhini M, et al. Among authors: nayak l. Indian J Hematol Blood Transfus. 2021 Jul;37(3):500-502. doi: 10.1007/s12288-020-01362-0. Epub 2020 Oct 7. Indian J Hematol Blood Transfus. 2021. PMID: 34267474 Free PMC article. No abstract available.
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001).
Agarwal A, Khandelwal A, Pal K, Khare NK, Jadhav V, Gurjar M, Punatar S, Gokarn A, Bonda A, Nayak L, Kannan S, Gota V, Khattry N, Mittra I. Agarwal A, et al. Among authors: nayak l. PLoS One. 2022 Feb 4;17(2):e0262212. doi: 10.1371/journal.pone.0262212. eCollection 2022. PLoS One. 2022. PMID: 35120140 Free PMC article.
Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant Setting.
Punatar S, Katti K, Rajamanickam D, Patil P, Dhakan C, Bagal B, Gokarn A, Bonda A, Nayak L, Gurjar M, Kannan S, Chiplunkar S, Gota V, Khattry N. Punatar S, et al. Among authors: nayak l. Cell Transplant. 2022 Jan-Dec;31:9636897221086969. doi: 10.1177/09636897221086969. Cell Transplant. 2022. PMID: 35435039 Free PMC article.
316 results